Page 86 | Certara

Blog

Latest PBPK Modeling Platform Advances Drug Development

In the ever-evolving pharmaceutical landscape, advancing drug development requires innovative tools that seamlessly integrate science…

CertaraApril 23, 2024

Conference

American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

CertaraApril 23, 2024

Announcement

Pinnacle 21 Releases New PMDA, FDA, NMPA Validation Engines

Pinnacle 21 by Certara announces the latest Validation Engines for submissions to Japan PMDA, US…

CertaraApril 23, 2024

Announcement

Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb

Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies,…

CertaraApril 18, 2024

White Paper

Advancing Therapeutic Development in Rare Diseases: Overcoming Key Challenges with Model-Informed Strategies

Read this white paper by Certara's expert Dr. Rajesh Krishna and learn about the core…

CertaraApril 18, 2024

Conference

BIO KOREA 2024

CertaraApril 17, 2024

Press Release

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraApril 16, 2024

Announcement

Certara Announces New Corporate Headquarters

New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and…

CertaraApril 15, 2024

Blog

What are biosimilars & how are they developed?

Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies…

CertaraApril 15, 2024

On-Demand Webinar

Exploring ADC pharmacokinetics using QSP

The Pharmacokinetics (PK) of ADC therapeutics typically show a discrepancy between the PK of total…

CertaraApril 12, 2024

Latest PBPK Modeling Platform Advances Drug Development

American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Pinnacle 21 Releases New PMDA, FDA, NMPA Validation Engines

Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb

Advancing Therapeutic Development in Rare Diseases: Overcoming Key Challenges with Model-Informed Strategies

BIO KOREA 2024

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

Certara Announces New Corporate Headquarters

What are biosimilars & how are they developed?

Exploring ADC pharmacokinetics using QSP

Newsletter sign up

Quick links

Solutions

Contact